Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Progen licenses preclinical cancer therapy from Unisearch

Sep. 20, 2002

MX-8899 evaluated in new radiation-induced dermatitis trial

Sep. 19, 2002

New anticancer product candidate at Ariad

Sep. 19, 2002

Novel sustained-release hydrogel-based formulation of paclitaxel compared to Taxol

Sep. 19, 2002

Angiogenesis inhibitors a focus of research at Kinetek

Sep. 19, 2002

Servier researchers report three series of FTase inhibitors

Sep. 19, 2002

IST-FS-29 effective in murine tumor models, well tolerated after repeated doses

Sep. 19, 2002

A novel COX-2 inhibitor may increase the antiproliferative effects of lovastatin in colon cancer

Sep. 19, 2002

Phase III Tarceva trial in NSCLC completes enrollment

Sep. 18, 2002

RPR-109881A: pharmacokinetics in patients with advanced solid tumors

Sep. 17, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...